CCL2 and COVID-19: It has been suggested from other studies that monitoring MCP-1 levels during hospitalisation could help prevent COVID-19 from progressing from a mild to a severe presentation (56); this finding is coherent with our XGB model of stratification of risk classes and the prominent ranking of this marker in the predictive order of importance.